We specialize in studying the interactions between biomolecules using electroanalytical methods to develop innovative analytical systems that can be applied in medicine, veterinary science, food analysis, and environmental protection.
We analyze interactions between biomolecules such as proteins and nucleic acids (DNA or RNA) using electrochemical methods.
These studies enable us to design and develop innovative platforms and analytical systems that can be used to construct electrochemical biosensors. A biosensor is an analytical device used to detect a specific analyte, containing two integrated elements: a biological recognition element (receptor) and a transducer.
For the recognition element, we use biological molecules: antibodies, single-stranded nucleic acids (ssDNA, ssRNA), and aptamers. Their role is to provide selectivity to the biosensor. We are particularly interested in innovative biosensors where the transducer element incorporates carbon or gold nanomaterials.
We focus on detecting biomarkers for various diseases, such as cancer, cardiovascular diseases, neurodegenerative diseases, and diabetes. The biosensors we develop have significant commercialization potential.
Another goal of our research is to determine the impact of selected compounds present in food on pathological processes in the human body, such as lipoprotein oxidation or protein aggregation. We are also engaged in studies on the inhibitory properties of new compounds on proteins that play key roles in the human body. Furthermore, we are working on systems for targeted and controlled delivery of therapeutically significant compounds to cancer cells.
